Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
21.73
+0.32 (1.49%)
At close: Nov 10, 2026, 4:00 PM EST
21.10
-0.63 (-2.90%)
After-hours: Nov 10, 2026, 7:59 PM EST

Structure Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
222.03799.62169.51129.7926.09105.31
Short-Term Investments
1,018646.57714.01337.5364.752
Cash & Short-Term Investments
1,2401,446883.52467.3290.84107.31
Cash Growth
55.18%63.69%89.06%414.44%-15.35%186.57%
Other Receivables
-100----
Receivables
-100----
Prepaid Expenses
35.1524.117.696.292.251.94
Total Current Assets
1,2751,570891.21473.6193.09109.25
Property, Plant & Equipment
16.8412.97.018.361.291.79
Long-Term Deferred Charges
----3.40.1
Other Long-Term Assets
42.460.725.110.050.060.01
Total Assets
1,3341,584903.33482.0297.85111.16

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
33.8813.868.024.746.013.48
Accrued Expenses
70.4646.5426.318.566.574.59
Current Portion of Leases
2.762.881.71.440.260.35
Current Income Taxes Payable
----0.170.23
Total Current Liabilities
107.163.2936.0224.7413.018.66
Long-Term Leases
4.073.612.164.01-0.27
Other Long-Term Liabilities
1.380.650.30.3--
Total Liabilities
112.5567.5438.4929.0513.018.93

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.020.020.0100
Additional Paid-In Capital
2,0241,9861,1936591.92-
Retained Earnings
-797.18-470.3-329.1-206.57-116.95-64.74
Comprehensive Income & Other
-4.691.050.910.52-0.11-
Total Common Equity
1,2221,516864.84452.97-115.14-64.74
Shareholders' Equity
1,2221,516864.84452.9784.84102.23
Total Liabilities & Equity
1,3341,584903.33482.0297.85111.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
6.836.493.865.450.260.62
Net Cash (Debt)
1,2331,440879.66461.8790.58106.69
Net Cash Growth
55.71%63.67%90.45%409.90%-15.10%187.06%
Net Cash Per Share
17.5324.3216.7112.5728.3539.31
Filing Date Shares Outstanding
71.5970.8457.3446.638.243.63
Total Common Shares Outstanding
71.3670.8457.2946.413.513.63
Working Capital
1,1681,507855.19448.8780.08100.59
Book Value Per Share
17.1221.4115.109.76-32.81-17.83
Tangible Book Value
1,2221,516864.84452.97-115.14-64.74
Tangible Book Value Per Share
17.1221.4115.109.76-32.81-17.83
Machinery
-6.813.752.511.271.15
Construction In Progress
-1.28----
Leasehold Improvements
-1.541.361.360.110.11
SEC Filings: 10-K · 10-Q